Health Care: Drugs

Protalix BioTherapeutics Inc (PLX: AMEX)

$0.33 0.01 | 3.12%
12/06/16 - 03:59 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 4.36M 3.52M 0.00 34.42M
Cost of Sales 730.00K 630.00K 0.00 4.45M
Gross Operating Profit 3.63M 2.89M 0.00 29.97M
Selling, General, and Administrative Expenses 7.28M 9.23M 8.05M 9.76M
Research & Development 20.02M 22.22M 26.01M 28.69M
Operating Income before D & A (EBITDA) -23.67M -28.56M -34.06M -8.48M
Depreciation & Amortization 2.37M 3.14M 3.54M 3.69M
Interest Income 123.00K 196.00K 391.00K 588.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -25.92M -31.50M -37.21M -11.58M
Interest Expense 3.73M 4.93M 1.06M 34.00K
Pre-Tax Income -29.65M -36.44M -38.28M -11.62M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -27.28M -33.30M -34.74M -11.62M
Net Income From Discontinued Operations 85.32M 3.35M 6.95M 0.00
Net Income From Total Operations 58.04M -29.94M -27.79M -11.62M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 58.04M -29.94M -27.79M -11.62M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-27.28M -33.30M -34.74M -11.62M
Preferred Dividends
Net Income Available To Common -27.28M -33.30M -34.74M -11.62M
Basic EPS from Continuing Ops. -0.29 -0.36 -0.38 -0.13
Basic EPS from Discontinued Ops. 0.90 0.04 0.08 0.00
Basic EPS from Total Operations 0.61 -0.32 -0.30 -0.13
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.61 -0.32 -0.30 -0.13
Basic Normalized Net Income/Share -0.29 -0.36 -0.38 -0.13
EPS fr Continuing Ops. -0.29 -0.36 -0.38 -0.13
EPS fr Discontinued Ops 0.90 0.04 0.08 0.00
EPS fr Total Ops. 0.61 -0.32 -0.30 -0.13
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.61 -0.32 -0.30 -0.13
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.29 -0.36 -0.38 -0.13
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PLX

Latest PLX Headlines from TheStreet

More Financial News for PLX

Press Releases for PLX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter